Skip to content

Effect of TENS on pain relief after surgery

Effect of Transcutaneous Electrical Nerve Stimulation on postoperative pain relief

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6cgx2k
Enrollment
Unknown
Registered
2018-02-01
Start date
2018-01-15
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A study conducted in humans submitted to abdominal or cardiac surgery in the HC of the UFTM. Thoracic surgery

Interventions

It will be a prospective, controlled, randomized, double-blind clinical trial including patients undergoing abdominal surgery and cardiac surgery at UFTM Hospital de Clínicas. Participants will be ran
Procedure/surgery
E02.331.800

Sponsors

Universidade Federal do Triângulo Mineiro
Lead Sponsor
Universidade Federal do Triângulo Mineiro
Collaborator

Eligibility

Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Age greater than 18 years; submitted to abdominal surgery (elective or complicated cholelithiasis, choledocholithiasis, obstructive jaundice, acute pacritatitis, acute cholestasis) and cardiac surgery that are hospitalized at the Hospital de Clínicas of UFTM; With post operative pain complaint; Ability to respond to assessment; Absence of provisional or definitive pacemaker; Sign the TCLE.

Exclusion criteria

Exclusion criteria: • Dehiscence or infection in the surgical incision with exposure of the injured skin; Tumors; New surgery during the intervention or death period; Supra renal disease, use of corticosteroids or steroid anti-inflammatory drugs that alter or influence the dosage of cortisol

Design outcomes

Primary

MeasureTime frame
As a primary endpoint or direct result, patients' pain relief in the postoperative period of cardiac and digestive surgeries is expected after the application of TENS.

Secondary

MeasureTime frame
And as a side effect it is expected that it will promote a reduction in analgesic consumption, helping to reduce symptoms such as nausea and emesis, as well as an increase in forced vital capacity and pulmonary tidal volume, increased respiratory muscle strength due to the facilitated physiotherapeutic treatment by the analgesic effect. A secondary effect on the immune system is also expected with the reduction of cytokines (IL1, IL6, IL10 and TNF) and cortisol.

Countries

Brazil

Contacts

Public ContactLuciane Martinho Fernandes

Universidade Federal do Triângulo Mineiro

fernandes.luciane72@gmail.com+55(34)992005151

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 18, 2026